MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
$238,682
EPS
$0.01
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Board of directors compensation
143,750
105,750
105,750
105,750
General and administrative
118,580
11,983
12,048
10,165
Total expenses
262,330
117,733
117,798
115,915
Loss from operations before other income and (expense)
-262,330
-117,733
-122,487.75*
-
Forgiveness of debt
502,373
-
-
-
Legal settlement
-
15,322
-
-
Loss on liability settlement
1,361
-
-3,882.75*
-
Loss from operations before loss on liability settlement
-
-
-
-115,915
Total other income and (expense)
501,012
15,322
-
-
Net income (loss) for the period
238,682
-102,411
-118,605
-115,915
Basic EPS
0.01
0
-0.004
0
Diluted EPS
0.01
0
-0.004
0
Basic Average Shares
33,544,161
33,521,755
33,853,603
33,521,755
Diluted Average Shares
33,544,161
33,521,755
33,539,219
33,521,755
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Forgiveness of debt
$502,373
Total other income and
(expense)
$501,012
Loss on liability
settlement
$1,361
Net income (loss)
for the period
$238,682
(294.40%↑ Y/Y)
Loss from operations
before other income and...
-$262,330
Total expenses
$262,330
(113.66%↑ Y/Y)
Board of directors
compensation
$143,750
(35.93%↑ Y/Y)
General and
administrative
$118,580
(596.26%↑ Y/Y)
Buy us a coffee
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)